HIT · XBRL financial data

Health In Tech financial statements, every quarter

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (HIT's year ends in late December)

In thousands of dollars	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue	4,905*	8,015	9,314	8,490	7,509*	8,772	8,057
Cost of revenue	1,107*	2,660	3,004	3,346	3,380*	4,262	4,134
Gross profit	3,797*	5,355	6,310	5,144	4,129*	4,509	3,922
Research and development	634*	538	583	236	213*	920	876
General and administrative	2,848*	3,247	3,775	3,452	3,180*	3,456	4,269
Total operating expenses	4,114*	4,875	5,585	4,650	4,299*	6,668	7,361
Interest income	29*	85	108	112	105*	67	70
Interest expense	0*	—	—	—	—	—	—
Income tax expense (benefit)	33*	186	203	148	(141)*	(480)	(810)
Net income (loss)	(144)*	499	631	452	(303)*	(1,588)	(2,511)
Earnings per share, basic USD per share	0.00*	0.01	0.01	0.01	(0.01)*	(0.03)	(0.04)
Earnings per share, diluted USD per share	0.00*	0.01	0.01	0.01	(0.01)*	(0.03)	(0.04)
Weighted average shares, basic thousands of shares	52,048*	54,620	55,382	56,432	56,909*	57,353	62,830
Weighted average shares, diluted thousands of shares	59,301*	56,997	55,632	58,774	59,528*	57,353	62,830

Fiscal quarters (HIT's year ends in late December)

In thousands of dollars	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	7,849	7,575	8,138	8,024	7,670	10,325	6,515
Accounts receivable	1,647	2,111	1,281	869	756	3,738	8,546
Prepaid and other current assets	787	1,805	1,513	2,118	3,280	2,865	2,380
Total current assets	10,784	15,572	14,854	15,047	16,161	22,088	21,784
Right-of-use asset	206	190	174	157	140	122	104
Total assets	15,768	21,330	22,178	22,756	23,090	28,966	29,635
Total current liabilities	2,131	6,754	5,390	5,238	5,157	7,047	9,989
Lease liability, non-current	140	122	103	84	64	43	22
Total liabilities	2,599	7,169	5,755	5,597	5,978	7,363	10,010
Retained earnings	3,941	4,440	5,071	5,523	5,220	3,632	1,121
Total stockholders' equity	13,169	14,161	16,424	17,159	17,112	21,603	—
Total liabilities and equity	15,768	21,330	22,178	22,756	23,090	28,966	29,635

Fiscal quarters (HIT's year ends in late December)

In thousands of dollars	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(144)*	499	631	452	(303)*	(1,588)	(2,511)
Stock-based compensation	year only	493	708*	293*	77*	367	959*
Depreciation and amortization	136*	136	136*	218*	411*	403	320*
Net cash from operating activities	(531)*	527	1,481*	674*	451*	(3,319)	(2,912)*
Net cash from investing activities	(542)*	(703)	(910)*	(745)*	(768)*	(362)	(597)*
Proceeds from issuing common stock	year only	8,214	0*	0*	—	6,381	0*
Net cash from financing activities	7,175*	(98)	(8)*	(44)*	(37)*	6,337	(301)*

SIC 6411 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 6411 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Health In Tech	6,515	8,057	(2,912)*	not reported	2.2 quarters	Q2 FY26 10-QJun 30, 2026
Sundance Strategies	17	not reported	(95)	43.1M	0.2 quarters	Q1 FY27 10-QJun 30, 2026
Reliance Global Group	1,807	2,111	(1,660)*	1.0M	1.1 quarters	Q2 FY26 10-QJun 30, 2026
GoHealth	39,879	not reported	6,986	not reported	—	Q1 FY26 10-QMar 31, 2026
Roadzen	6,004	16,194	(5,473)	85.2M	1.1 quarters	Q1 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.